ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
Stock Market Commentary Last week featured an intense barrage of earnings reports. The collective response on the major indices was a major yawn. The S&P 500 finished flat for the week. The NASDAQ and the iShares Trust Russell 2000 Index ETF both softened by 0.4%. Financials were a notable exception as the Financial Select Sector … Read more
Stock Market Commentary A week ago, the fading of the growth tantrum further solidified my bullish read on the stock market. Last week, big cap tech took over from the growth tantrum. Buyers passed the baton in impression fashion but left small caps behind. Regardless, market dips are attracting buyers in a rotating fashion. The … Read more
I have been a fan of genetic testing company Invitae (NVTA) for six years. My interest started after I heard co-founder (and now President, CEO, and Chairman) Sean George give a talk at the Stanford Technology Ventures Program. He titled the 2015 talk “Experience Is Your Reward.” George talked about facing down challenges and adversity … Read more
Soliton (SOLY) is a pre-launch medical device company specializing in technology for tattoo removal and cellulite reduction. The company is working on extending its RAP (Rapid Acoustic Pulse) technology to other indications. Soliton is still pre-launch, so the company had little to report for its financials in its latest earnings report. Management spent most of … Read more
